Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies

Co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies

US Patent 12319735 · Granted Jun 3, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies2023
Formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies2023
Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods2023
Pharmaceutical formulation comprising incretin-insulin conjugates2023
Pharmaceutical formulations of (S)-methyl(1-((4-(3-(5-chloro-2-fluoro-3-(methyls2020
Method of treating colorectal cancer by administration of pharmaceutical formula2019
Liquid formulations for an anti-TNF α antibody2017
Method of treating melanoma by administration of pharmaceutical formulations of 2017
Biodegradable particulate formulations2017